QN
QNTPF.US XtalPi Holdings Limited
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is QNTPF.US undervalued?
Graham numberThe Graham number of XtalPi Holdings Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
XtalPi Holdings Limited fundamental analysis
No fundamental analysis for XtalPi Holdings Limited yet.
XtalPi Holdings Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About XtalPi Holdings Limited
XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and…
Full company profileFinancial statements of XtalPi Holdings Limited are not available yet.
XtalPi Holdings Limited dividends
XtalPi Holdings Limited has not paid dividends in the last 2 fiscal years.
Who owns XtalPi Holdings Limited
- Insiders 15.40%
- Institutions 15.91%
- Public & others 68.70%
- Free float 3.44B
XtalPi Holdings Limited company profile
- Company name
- XtalPi Holdings Limited
- Ticker
- QNTPF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 1,623
- Fiscal year end
- December
- Address
- Second Phase of the International, Shenzhen, China
- Phone
- 86 755 8190 1777
- Website
- xtalpi.com
About XtalPi Holdings Limited
XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and drug discovery solutions, such as hit discovery, hit or lead optimization, and biology capabilities, as well as PepiX, which generates stable peptides. In addition, the company offers discovery chemistry solutions, including automation-aided chemical synthesis and focused library; and XtalGazer, a solid-state research solution. It has a strategic collaboration with Pfizer to co-build an AI-driven molecular simulation research and development platform; DoveTree to develop therapeutics designed for multiple difficult-to-drug targets; and strategic partnership with an international biopharmaceutical company to develop oral small molecule therapeutics for a GPCR target. The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024. XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China.
XtalPi Holdings Limited management
8- Dr. Shuhao WenCo-Founder & Executive Chairman of Board · born 1983
- Dr. Jian Ma Ph.D.Co-Founder, CEO & Executive Director · born 1986
- Dr. Lipeng LaiCo-Founder, Chief Innovation Officer & Executive Director · born 1984
- Dr. Yide JiangChief Strategic Officer & Executive Director · born 1964
- Mr. Feiran ZhouChief Financial Officer · born 1986
- Dr. Peiyu ZhangChief Scientific Officer · born 1984
- Ms. Sau Ling Chan ACIS, ACS(PE), FCIS, P.E.Joint Company Secretary · born 1970
- Ms. Shimei LiuJoint Company Secretary